Back
Virtus AllianzGI Dividend Interest & Premium Strategy Fund Vs. Corcept Therapeutics, Inc. Industry Stock Comparison
Buy
59
NFJ
Virtus AllianzGI Dividend Interest & Premium Strategy Fund
Last Price:
$12.91
Seasonality Move:
0.43%
Sell
36
CORT
Corcept Therapeutics, Inc.
Last Price:
$70.27
Seasonality Move:
6.8%
Buy
59
Virtus AllianzGI Dividend Interest & Premium Strategy Fund (NFJ)
is a Buy
Is Virtus AllianzGI Dividend Interest & Premium Strategy Fund a Buy, Sell or Hold?
-
The current Virtus AllianzGI Dividend Interest & Premium Strategy Fund [NFJ] share price is $12.94. The Score for NFJ is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
NFJ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Corcept Therapeutics, Inc. (CORT)
is a Sell
Is Corcept Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Corcept Therapeutics, Inc. [CORT] share price is $70.20. The Score for CORT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
CORT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NFJ Stock Price Chart
What is Virtus AllianzGI Dividend Interest & Premium Strategy Fund's stock price today?
-
The Virtus AllianzGI Dividend Interest & Premium Strategy Fund share price today is $12.94Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NFJ is experiencing slight selling pressure.
CORT Stock Price Chart
What is Corcept Therapeutics, Inc.'s stock price today?
-
The Corcept Therapeutics, Inc. share price today is $70.20Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CORT is experiencing selling pressure, which indicates risk of future bearish movement.
NFJ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 53.27 | Buy |
| Chaikin Money Flow: | -83316 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.71 - 13.09) | Buy |
| Bollinger Bands (100): | (12.72 - 13.06) | Buy |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 32.16 | Sell |
| Chaikin Money Flow: | -2244663 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (78.7 - 85.94) | Sell |
| Bollinger Bands (100): | (71.38 - 83.18) | Sell |
NFJ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.83 | Buy |
| 20-day SMA: | 12.93 | Buy |
| 50-day SMA: | 12.87 | Buy |
| 200-day SMA: | 12.48 | Buy |
| 8-day EMA: | 12.88 | Buy |
| 20-day EMA: | 12.88 | Buy |
| 50-day EMA: | 12.88 | Buy |
| 200-day EMA: | 12.69 | Buy |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 81.08 | Sell |
| 20-day SMA: | 83.06 | Sell |
| 50-day SMA: | 78.49 | Sell |
| 200-day SMA: | 74.04 | Sell |
| 8-day EMA: | 79.79 | Sell |
| 20-day EMA: | 81.21 | Sell |
| 50-day EMA: | 78.92 | Sell |
| 200-day EMA: | 51.36 | Buy |
Virtus AllianzGI Dividend Interest & Premium Strategy Fund Earnings Growth & NFJ Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corcept Therapeutics, Inc. Earnings Growth & CORT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and an increase next year of $3.11 per share.
Virtus AllianzGI Dividend Interest & Premium Strategy Fund Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||